This article was originally published in The Gray Sheet
NuVasive appoints executive VP, general counsel; Danaher names senior VP and general counsel; and genomic informatics company Human Longevity acquires Cypher Genomics, and in the process names Cypher CEO Ashley Van Zeeland as head of the firm's pediatric business.
You may also be interested in...
Hill-Rom's acquisition of Welch Allyn speeds ahead; Nuvasive builds its team; Philips divests pediatric respiratory products.
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Among the largest gaps in safety data is non-clinical research on CBD use's effect on developing fetus and adolescent brain, in utero/lactational exposure, reproductive toxicity and the potential for a latency period before toxicity, says FDA neuroscientist Andrew Shen.